ArticleInternational journal of molecular sciences2024

Potential of NRF2 Inhibitors-Retinoic Acid, K67, and ML-385-In Overcoming Doxorubicin Resistance in Promyelocytic Leukemia Cells.

Michał Juszczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.